Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Multiple MyelomaAMLBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Sequential Targeted Treatment for a Geriatric Patient with Acute Myeloid Leukemia with Concurrent FLT3-TKD and IDH1 MutationsJanuary 7, 2021AMLHematologyOncology
Black race linked to poorer survival in AMLDecember 10, 2020AMLLeukemia, Myelodysplasia, Transplantation
Beat AML: Precision medicine strategy feasible, superior to SOC for AMLNovember 10, 2020AMLLeukemia, Myelodysplasia, Transplantation
Novel agents hold promise for frontline AML treatmentOctober 28, 2020AMLLeukemia, Myelodysplasia, TransplantationHematology
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020Breast CancerLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerMelanomaLymphoma & Plasma Cell Disorders
Don’t overlook treating older patients with acute promyelocytic leukemia, expert saysJuly 17, 2020AMLLeukemia, Myelodysplasia, Transplantation
First-in-kind anti-CD47 antibody shows promise for MDS and AML treatmentJune 19, 2020AMLLeukemia, Myelodysplasia, TransplantationHematology
Risk index stratifies pediatric leukemia patients undergoing HSCTJune 8, 2020AMLHematologyOncologyLeukemia, Myelodysplasia, Transplantation
Survival for older AML patients better with HSCT from unrelated donorsFebruary 8, 2020AMLLeukemia, Myelodysplasia, Transplantation
9/11 responders show increased risk of leukemia, other cancersJanuary 14, 2020Leukemia, Myelodysplasia, TransplantationAMLOncology
Kidney function in African American AML patients not linked to reduced survival compared with whitesDecember 7, 2019AMLLeukemia, Myelodysplasia, TransplantationHematology
Will TP53-mutated AML respond to immunotherapy?November 18, 2019AMLLeukemia, Myelodysplasia, Transplantation
Adverse cytogenetics trump molecular risk in NPM1-mutated AMLOctober 15, 2019AMLLeukemia, Myelodysplasia, Transplantation
For tough AML, half respond to selinexor plus chemotherapyJune 25, 2019AMLLeukemia, Myelodysplasia, TransplantationHematology
